Clinical Use of [TIMP-2]•[IGFBP7] Biomarker Testing to Assess Risk of Acute Kidney Injury in Critical Care: Guidance From an Expert Panel

Critical Care - United Kingdom
doi 10.1186/s13054-019-2504-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Utility of Trend of Nephrocheck® (IGFBP7 × TIMP-2) Biomarker for Early Identification of Acute Kidney Injury in Critically Ill Patients With Sepsis or Respiratory Failure

Journal of Clinical Nephrology and Renal Care
2018English

Diagnostic Prediction of Urinary [TIMP-2] X [IGFBP7] for Acute Kidney Injury: A Meta-Analysis Exploring Detection Time and Cutoff Levels

Oncotarget
Oncology
2017English

Tissue Inhibitor Metalloproteinase-2 (TIMP-2) • IGF-binding Protein-7 (IGFBP7) Levels Are Associated With Adverse Outcomes in Patients in the Intensive Care Unit With Acute Kidney Injury

Kidney International
Nephrology
2019English

Clinical Characteristics Analysis on Acute Kidney Injury of Patients in Department of Critical Care Medicine

2018English

Critical Care Nephrology: It's Not Just Acute Kidney Injury

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Access Management in Primary Care: Perspectives From an Expert Panel

2018English

Renal Replacement Therapy in Critical Care in Patients With Acute Kidney Injury

Nihon Toseki Igakkai Zasshi
2018English

Acute Kidney Injury in Non-Critical Care Setting: Elaboration and Validation of an In-Hospital Death Prognosis Score

BMC Nephrology
Nephrology
2019English

Clinical Features and Risk Factors of Acute Kidney Injury in Children With Acute Paraquat Intoxication

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy